Skip to main content

Characterization of SGLT-2 Inhibitor Users in the Patient-Centered Clinical Research Network (PCORnet)

    Basic Details
    Date Posted
    Medical Product
    sodium-glucose cotransporter-2 (SGLT-2) inhibitor

    The objective of this request was to assess the feasibility of using national Patient-Centered Clinical Research Network (PCORnet) data to complement results from queries run against the Sentinel Distributed Database (SDD). PCORnet is comprised of electronic health record data. This request aims to describe the demographic, vital, and clinical characteristics of patients receiving a prescription for sodium-glucose cotransporter-2 (SGLT-2) inhibitors and other select anti-diabetic medications.

    We used a retrospective study design to identify prevalent users of SGLT-2 inhibitors or sitagliptin within the PCORnet network between March 1, 2013, and June 30, 2018. We included data from 25 PCORnet Data Marts in this report. We distributed this request on October 2, 2019.

    Additional Details
    FDA Center
    Time Period
    March 1, 2013 - June 30, 2018
    Analysis Type
    PCORnet Descriptive Analysis
    Population / Cohort
    All individuals
    Data Sources
    Patient-Centered Clinical Research Network (PCORnet)